main-logo

ICD-10 Code C90.31 | Solitary plasmacytoma in remission Symptoms, Diagnosis, Billing

Solitary plasmacytoma in remission is a localized form of plasma cell neoplasm characterized by the presence of a single tumor of monoclonal plasma cells. It is clinically significant as it indicates a stage of disease where the tumor is no longer active, allowing for appropriate management and monitoring. The ICD-10 Code C90.31 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can track treatment outcomes and resource utilization effectively.

What is ICD-10 Code C90.31 for Solitary plasmacytoma in remission?

ICD-10 Code C90.31 represents solitary plasmacytoma in remission, a condition where a single plasma cell tumor has responded to treatment and is no longer active. This code is used in clinical documentation and billing to indicate that the patient has achieved remission, which is crucial for treatment planning, follow-up care, and ensuring appropriate reimbursement for healthcare services.

ICD-10 Code C90.31 – Clinical Definition and Explanation of Solitary plasmacytoma in remission

Solitary plasmacytoma in remission occurs when a localized plasma cell tumor has been treated successfully, resulting in the absence of active disease. This condition requires ongoing monitoring to prevent progression to multiple myeloma. Medical attention is necessary to manage potential complications and ensure continued remission.

Key Clinical Features:

  • Presence of a single tumor of monoclonal plasma cells.
  • Absence of systemic symptoms or signs of multiple myeloma.
  • Regular follow-up imaging and laboratory tests to monitor for recurrence.
  • Potential for progression to multiple myeloma if not monitored.

ICD-10 Code C90.31 for Solitary plasmacytoma in remission – SOAP Notes & Clinical Use

ICD-10 Code C90.31 is utilized in SOAP notes to document the patient's remission status, guiding treatment decisions and follow-up care. It plays a critical role in both acute and chronic care settings, ensuring that healthcare providers have a clear understanding of the patient's condition and treatment history.

What Does ICD-10 Code C90.31 for Solitary plasmacytoma in remission Mean in SOAP Notes?

In SOAP notes, ICD-10 Code C90.31 connects subjective patient reports and objective clinical findings to a formal diagnosis of solitary plasmacytoma in remission. This code is essential for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code C90.31 – Solitary plasmacytoma in remission

Management of solitary plasmacytoma in remission focuses on monitoring and supportive care to maintain remission status. Treatment may include disease-specific approaches to prevent recurrence.

Antibiotic Therapy:

  • Not applicable as solitary plasmacytoma is not infectious.

Supportive Care:

  • Regular follow-up appointments for monitoring.
  • Pain management strategies as needed.
  • Physical therapy to maintain mobility and strength.

Infection Control:

  • Standard precautions to prevent infections during treatment.

How to Document Symptoms of Solitary plasmacytoma in remission (ICD-10 C90.31) in SOAP Notes

Subjective:

  • Patient reports no current symptoms related to the plasmacytoma.
  • History of localized pain at the site of the tumor, now resolved.
  • Patient expresses concern about potential recurrence.

Objective:

  • Physical examination shows no palpable masses.
  • Imaging studies indicate no evidence of active disease.
  • Laboratory tests show normal serum protein levels.
card-topcard-bottom

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more
hipaa-icon

SOAP Note Guidelines for Diagnosing Solitary plasmacytoma in remission (ICD-10 Code C90.31)

Assessment:

  • Diagnosis: Solitary plasmacytoma in remission, stable condition.
  • ICD-10 Code: C90.31.
  • No current symptoms or signs of progression.

Plan:

  • Continue regular follow-up every 3-6 months.
  • Monitor serum protein levels and imaging studies.
  • Educate patient on signs of recurrence and when to seek care.

Treatment & Plan Section for ICD-10 Code C90.31 – Solitary plasmacytoma in remission

  • Regular follow-up appointments to monitor for recurrence.
  • Education on lifestyle modifications to support health.
  • Pain management as needed, with appropriate referrals.
  • Consideration of bisphosphonates for bone health if indicated.

Using ICD-10 Code C90.31 for Solitary plasmacytoma in remission in Billing & SOAP Note Compliance

  • Ensure accurate documentation of the patient's remission status.
  • Use C90.31 in conjunction with relevant clinical findings in SOAP notes.
  • Align treatment plans with clinical guidelines to support billing.
  • Document any related symptoms or complications clearly.

ICD-10 Code C90.31 in Medical Billing and Insurance for Solitary plasmacytoma in remission

ICD-10 Code C90.31 is crucial for billing purposes, particularly in hospital, ER, or oncology settings, as it indicates the patient's remission status.

Billing Notes:

  • Document the patient's remission status clearly in medical records.
  • Use C90.31 in appropriate clinical settings to support claims.
  • Include relevant clinical findings and treatment plans in documentation.

Common CPT Pairings:

CPT CodeDescription
99213Established patient office visit, moderate complexity.
36415Collection of venous blood by venipuncture.
85025Complete blood count with automated differential.

Frequently Asked Questions

Common Questions About Using ICD-10 Code C90.31 for Solitary plasmacytoma in remission

What does it mean if a patient has solitary plasmacytoma in remission?

It indicates that the patient had a localized plasma cell tumor that has responded to treatment and is currently inactive, requiring ongoing monitoring to prevent recurrence.

How is solitary plasmacytoma in remission monitored?

Monitoring typically involves regular follow-up appointments, imaging studies, and laboratory tests to assess for any signs of recurrence or progression.

Can solitary plasmacytoma in remission progress to multiple myeloma?

Yes, solitary plasmacytoma can progress to multiple myeloma if not monitored closely, which is why regular follow-up is essential.

What are the treatment options for solitary plasmacytoma in remission?

Treatment primarily focuses on monitoring and supportive care, including pain management and physical therapy, as the condition is not infectious.

diamond-bg
diamond-bg

Get started with your 20 free notes

Sign up for free
main-logo

AI-aided Sudsy Shorthand for ink-free practices

support@soapsuds.io
hipaa-logo

Clinical Notes

SOAP notes

DAP notes

AI medical notes

© Copyright SOAPsuds 2025. All rights reserved